1 SGPP Mitgliederumfrage zu COVID-19: Pandemiebedingte Veränderungen der ambulanten psychiatrischpsychotherapeutschen Versorgung 2022.
4 Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, et al. (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. European Neuropsychopharmacology, 21: 655–79.
5 Wittchen HU, Jacobi F. (2005). Size and burden of mental disorders in Europe – a critical review and appraisal of 27 studies. European Neuropsychopharmacology, 15(4): 357–76.
6 Jacobi F, Höfler M, Strehle J, Mack S, Gerschler A, Scholl L, et al. (2014). Psychische Störungen in der Allgemeinbevölkerung. Der Nervenarzt, 85(1): 77–87.
7 WHO. Fact sheet on depression, updated February 2017. Depression is the leading cause of disability worldwide, and is a major contributor to the overall global burden of disease.
8 Kessler RC, Demler O, Frank RG, Olfson M, Pincus HA, Walters EE. (2005b). Prevalence and treatment of mental disorders, 1990 to 2003. The New England Journal of Medicine, 352(24): 2515–23.
9 Jäggi J, Künzi K, deWijn N, Stocker D. BASS, Schlussbericht: Vergleich der Tätigkeiten von Psychiaterinnen und Psychiatern in der Schweiz und im Ausland. 9. März 2017.
10 Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, et al. (2016). Scaling-up treatment of depression and anxiety: a global return on investment analysis. The Lancet Psychiatry, 3(5): 415–24.